Skip to main content
Erschienen in: Diseases of the Colon & Rectum 11/2006

01.11.2006 | Original Contributions

Indication and Benefit of Pelvic Sidewall Dissection for Rectal Cancer

verfasst von: Kenichi Sugihara, M.D., Hirotoshi Kobayashi, M.D., Tomoyuki Kato, M.D., Takeo Mori, M.D., Hidetaka Mochizuki, M.D., Shingo Kameoka, M.D., Kazuo Shirouzu, M.D., Tetsuichiro Muto, M.D.

Erschienen in: Diseases of the Colon & Rectum | Ausgabe 11/2006

Einloggen, um Zugang zu erhalten

Purpose

This study was designed to clarify indication and benefit of pelvic sidewall dissection for rectal cancer.

Methods

The retrospective, multicenter study collected the data of rectal cancer patients who underwent surgery between 1991 and 1998 and were prospectively followed.

Results

Of 1,977 patients with rectal cancers, 930 underwent pelvic sidewall dissection without adjuvant radiotherapy. Positive lateral lymph nodes were found in 129. Multivariate analysis disclosed a significantly increased incidence of positive lateral lymph nodes in female gender, lower rectal cancers, non-well-differentiated adenocarcinoma, tumor size of ≥4 cm and T3-T4. The five-year survival rate for 1,977 patients was 79.7 percent. The survival of patients with positive lateral lymph nodes was significantly worse than that of Stage III patients with negative lateral lymph nodes (45.8 vs. 71.2 percent, P<0.0001). Multivariate analysis showed significantly worse prognosis in male gender, pelvic sidewall dissection, lower rectal cancers, T3-T4, perirectal lymph node metastasis, and positive lateral lymph nodes. During the median follow-up time of 57 months, recurrence developed in 19.7 percent: 17 percent in negative and 58.1 percent in positive lateral lymph nodes (P<0.0001). Local recurrence was found in 8 percent: 6.8 percent in negative and 25.6 percent in positive lateral lymph nodes (P<0.0001). Multivariate analysis disclosed that lower rectal cancers, non-well-differentiated adenocarcinoma, T3-T4, perirectal lymph node metastasis, and positive lateral lymph nodes were significantly associated with an increased local recurrence.

Conclusions

Positive lateral lymph node was the strongest predictor in both survival and local recurrence. Pelvic sidewall dissection may be indicated for patients with T3-T4 lower rectal cancers because of the greater provability of positive lateral lymph nodes.
Literatur
1.
Zurück zum Zitat Dahl, O, Horn, A, Morild, I, et al. 1990Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicenter trial in western NorwayCancer6622862294PubMedCrossRef Dahl, O, Horn, A, Morild, I,  et al. 1990Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicenter trial in western NorwayCancer6622862294PubMedCrossRef
2.
Zurück zum Zitat Marsh, PJ, James, RD, Schofield, PF 1994Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma. Results of a prospective, randomized trialDis Colon Rectum3712051214PubMedCrossRef Marsh, PJ, James, RD, Schofield, PF 1994Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma. Results of a prospective, randomized trialDis Colon Rectum3712051214PubMedCrossRef
3.
Zurück zum Zitat Holm, T, Rutqvist, LE, Johansson, H, Cedermark, B 1995Abdominoperineal resection and anterior resection in the treatment of rectal cancer: results in relation to adjuvant preoperative radiotherapyBr J Surg8212131216PubMed Holm, T, Rutqvist, LE, Johansson, H, Cedermark, B 1995Abdominoperineal resection and anterior resection in the treatment of rectal cancer: results in relation to adjuvant preoperative radiotherapyBr J Surg8212131216PubMed
4.
Zurück zum Zitat Anonymous1996Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working PartyLancet34816051610CrossRef Anonymous1996Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working PartyLancet34816051610CrossRef
5.
Zurück zum Zitat Anonymous1997Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer TrialN Engl J Med336980987CrossRef Anonymous1997Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer TrialN Engl J Med336980987CrossRef
6.
Zurück zum Zitat Treurniet-Donker, AD, Putten, WL, Wereldsma, JC, Bruggink, MD 1991Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in The NetherlandsCancer6720422048PubMedCrossRef Treurniet-Donker, AD, Putten, WL, Wereldsma, JC, Bruggink, MD 1991Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in The NetherlandsCancer6720422048PubMedCrossRef
7.
Zurück zum Zitat Anonymous1996Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Medical Research Council Rectal Cancer Working PartyLancet34816101614CrossRef Anonymous1996Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Medical Research Council Rectal Cancer Working PartyLancet34816101614CrossRef
8.
Zurück zum Zitat Arnaud, JP, Nordlinger, B, Bosset, JF, et al. 1997Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of CancerBr J Surg84352357PubMedCrossRef Arnaud, JP, Nordlinger, B, Bosset, JF,  et al. 1997Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of CancerBr J Surg84352357PubMedCrossRef
9.
Zurück zum Zitat Heald, RJ, Husband, EM, Ryall, RD 1982The mesorectum in rectal cancer surgery–the clue to pelvic recurrence?Br J Surg69613616PubMed Heald, RJ, Husband, EM, Ryall, RD 1982The mesorectum in rectal cancer surgery–the clue to pelvic recurrence?Br J Surg69613616PubMed
10.
Zurück zum Zitat Enker, WE 1992Potency, cure, and local control in the operative treatment of rectal cancerArch Surg12713961402PubMed Enker, WE 1992Potency, cure, and local control in the operative treatment of rectal cancerArch Surg12713961402PubMed
11.
Zurück zum Zitat Hojo, K, Koyama, Y, Moriya, Y 1982Lymphatic spread and its prognostic value in patients with rectal cancerAm J Surg144350354PubMedCrossRef Hojo, K, Koyama, Y, Moriya, Y 1982Lymphatic spread and its prognostic value in patients with rectal cancerAm J Surg144350354PubMedCrossRef
12.
Zurück zum Zitat Koyama, Y, Moriya, Y, Hojo, K 1984Effects of extended systematic lymphadenectomy for adenocarcinoma of the rectum–significant improvement of survival rate and decrease of local recurrenceJpn J Clin Oncol14623632PubMed Koyama, Y, Moriya, Y, Hojo, K 1984Effects of extended systematic lymphadenectomy for adenocarcinoma of the rectum–significant improvement of survival rate and decrease of local recurrenceJpn J Clin Oncol14623632PubMed
13.
Zurück zum Zitat Camma, C, Giunta, M, Fiorica, F, et al. 2000Preoperative radiotherapy for resectable rectal cancer: a meta-analysisJAMA28410081015PubMedCrossRef Camma, C, Giunta, M, Fiorica, F,  et al. 2000Preoperative radiotherapy for resectable rectal cancer: a meta-analysisJAMA28410081015PubMedCrossRef
14.
Zurück zum Zitat Colorectal Cancer Collaborative Group2001Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trialsLancet35812911304CrossRef Colorectal Cancer Collaborative Group2001Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trialsLancet35812911304CrossRef
15.
Zurück zum Zitat Enker, WE, Thaler, HT, Cranor, ML, Polyak, T 1995Total mesorectal excision in the operative treatment of carcinoma of the rectumJ Am Coll Surg181335346PubMed Enker, WE, Thaler, HT, Cranor, ML, Polyak, T 1995Total mesorectal excision in the operative treatment of carcinoma of the rectumJ Am Coll Surg181335346PubMed
16.
Zurück zum Zitat Leo, E, Belli, F, Andreola, S, et al. 2000Total rectal resection and complete mesorectum excision followed by coloendoanal anastomosis as the optimal treatment for low rectal cancer: the experience of the National Cancer Institute of MilanoAnn Surg Oncol7125132PubMedCrossRef Leo, E, Belli, F, Andreola, S,  et al. 2000Total rectal resection and complete mesorectum excision followed by coloendoanal anastomosis as the optimal treatment for low rectal cancer: the experience of the National Cancer Institute of MilanoAnn Surg Oncol7125132PubMedCrossRef
17.
Zurück zum Zitat Law, WL, Chu, KW 2001Impact of total mesorectal excision on the results of surgery of distal rectal cancerBr J Surg8816071612PubMedCrossRef Law, WL, Chu, KW 2001Impact of total mesorectal excision on the results of surgery of distal rectal cancerBr J Surg8816071612PubMedCrossRef
18.
Zurück zum Zitat Kapiteijn, E, Marijnen, CA, Nagtegaal, ID, et al. 2001Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancerN Engl J Med345638646PubMedCrossRef Kapiteijn, E, Marijnen, CA, Nagtegaal, ID,  et al. 2001Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancerN Engl J Med345638646PubMedCrossRef
19.
Zurück zum Zitat Tocchi, A, Mazzoni, G, Lepre, L, et al. 2001Total mesorectal excision and low rectal anastomosis for the treatment of rectal cancer and prevention of pelvic recurrencesArch Surg136216220PubMedCrossRef Tocchi, A, Mazzoni, G, Lepre, L,  et al. 2001Total mesorectal excision and low rectal anastomosis for the treatment of rectal cancer and prevention of pelvic recurrencesArch Surg136216220PubMedCrossRef
20.
Zurück zum Zitat Vironen, JH, Halme, L, Sainio, P, et al. 2002New approaches in the management of rectal carcinoma result in reduced local recurrence rate and improved survivalEur J Surg168158164PubMedCrossRef Vironen, JH, Halme, L, Sainio, P,  et al. 2002New approaches in the management of rectal carcinoma result in reduced local recurrence rate and improved survivalEur J Surg168158164PubMedCrossRef
21.
Zurück zum Zitat Bulow, S, Christensen, IJ, Harling, H, et al. 2003Recurrence and survival after mesorectal excision for rectal cancerBr J Surg90974980PubMedCrossRef Bulow, S, Christensen, IJ, Harling, H,  et al. 2003Recurrence and survival after mesorectal excision for rectal cancerBr J Surg90974980PubMedCrossRef
22.
Zurück zum Zitat Wibe, A, Syse, A, Andersen, E, Tretli, S, Myrvold, HE 2004Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resectionDis Colon Rectum474858PubMedCrossRef Wibe, A, Syse, A, Andersen, E, Tretli, S, Myrvold, HE 2004Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resectionDis Colon Rectum474858PubMedCrossRef
23.
Zurück zum Zitat Heald, RJ, Moran, BJ, Ryall, RD, et al. 1998Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997Arch Surg133894899PubMedCrossRef Heald, RJ, Moran, BJ, Ryall, RD,  et al. 1998Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997Arch Surg133894899PubMedCrossRef
24.
Zurück zum Zitat Zaheer, S, Pemberton, JH, Farouk, R, et al. 1998Surgical treatment of adenocarcinoma of the rectumAnn Surg227800811PubMedCrossRef Zaheer, S, Pemberton, JH, Farouk, R,  et al. 1998Surgical treatment of adenocarcinoma of the rectumAnn Surg227800811PubMedCrossRef
25.
Zurück zum Zitat Hainsworth, PJ, Egan, MJ, Cunliffe, WJ 1997Evaluation of a policy of total mesorectal excision for rectal and rectosigmoid cancersBr J Surg84652656PubMedCrossRef Hainsworth, PJ, Egan, MJ, Cunliffe, WJ 1997Evaluation of a policy of total mesorectal excision for rectal and rectosigmoid cancersBr J Surg84652656PubMedCrossRef
26.
Zurück zum Zitat Lopez-Kostner, F, Lavery, IC, Hool, GR, et al. 1998Total mesorectal excision is not necessary for cancers of the upper rectumSurgery124612618PubMedCrossRef Lopez-Kostner, F, Lavery, IC, Hool, GR,  et al. 1998Total mesorectal excision is not necessary for cancers of the upper rectumSurgery124612618PubMedCrossRef
27.
Zurück zum Zitat Hahnloser, D, Pemberton, JH 2003Total mesorectal excision for all rectal cancers [editorial]Surgery1336667PubMedCrossRef Hahnloser, D, Pemberton, JH 2003Total mesorectal excision for all rectal cancers [editorial]Surgery1336667PubMedCrossRef
28.
Zurück zum Zitat Akasu, T, Moriya, Y 1997Abdominopelvic lymphadenectomy with autonomic nerve preservation for carcinoma of the rectumLippincott-RavenPhiladelphia Akasu, T, Moriya, Y 1997Abdominopelvic lymphadenectomy with autonomic nerve preservation for carcinoma of the rectumLippincott-RavenPhiladelphia
29.
Zurück zum Zitat Scholefield, JH, Steup, WH 1992Surgery for rectal cancer in Japan [letter]Lancet3401101PubMedCrossRef Scholefield, JH, Steup, WH 1992Surgery for rectal cancer in Japan [letter]Lancet3401101PubMedCrossRef
30.
Zurück zum Zitat Harnsberger, JR, Vernava, VM,3rd, Longo, WE 1994Radical abdominopelvic lymphadenectomy: historic perspective and current role in the surgical management of rectal cancerDis Colon Rectum377387PubMedCrossRef Harnsberger, JR, Vernava, VM,3rd, Longo, WE 1994Radical abdominopelvic lymphadenectomy: historic perspective and current role in the surgical management of rectal cancerDis Colon Rectum377387PubMedCrossRef
31.
Zurück zum Zitat Sugihara, K, Moriya, Y, Akasu, T, Fujita, S 1996Pelvic autonomic nerve preservation for patients with rectal carcinoma. Oncologic and functional outcomeCancer7818711880PubMedCrossRef Sugihara, K, Moriya, Y, Akasu, T, Fujita, S 1996Pelvic autonomic nerve preservation for patients with rectal carcinoma. Oncologic and functional outcomeCancer7818711880PubMedCrossRef
32.
Zurück zum Zitat Mori, T, Takahashi, K, Yasuno, M 1998Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissectionLangenbecks Arch Surg383409415PubMedCrossRef Mori, T, Takahashi, K, Yasuno, M 1998Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissectionLangenbecks Arch Surg383409415PubMedCrossRef
33.
Zurück zum Zitat Lowry, AC, Simmang, CL, Boulos, P, et al. 2001Consensus statement of definitions for anorectal physiology and rectal cancer: report of the Tripartite Consensus Conference on Definitions for Anorectal Physiology and Rectal Cancer, Washington, D.C., May 1, 1999Dis Colon Rectum44915919PubMedCrossRef Lowry, AC, Simmang, CL, Boulos, P,  et al. 2001Consensus statement of definitions for anorectal physiology and rectal cancer: report of the Tripartite Consensus Conference on Definitions for Anorectal Physiology and Rectal Cancer, Washington, D.C., May 1, 1999Dis Colon Rectum44915919PubMedCrossRef
34.
Zurück zum Zitat Japanese Society for Cancer of the Colon and Rectum1997Japanese classification of colorectal carcinomaKaneharaTokyo Japanese Society for Cancer of the Colon and Rectum1997Japanese classification of colorectal carcinomaKaneharaTokyo
35.
Zurück zum Zitat Canessa, CE, Miegge, LM, Bado, J, Silveri, C, Labandera, D 2004Anatomic study of lateral pelvic lymph nodes: implications in the treatment of rectal cancerDis Colon Rectum47297303PubMedCrossRef Canessa, CE, Miegge, LM, Bado, J, Silveri, C, Labandera, D 2004Anatomic study of lateral pelvic lymph nodes: implications in the treatment of rectal cancerDis Colon Rectum47297303PubMedCrossRef
36.
Zurück zum Zitat Moriya, Y, Sugihara, K, Akasu, T, Fujita, S 1997Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancerWorld J Surg21728732PubMedCrossRef Moriya, Y, Sugihara, K, Akasu, T, Fujita, S 1997Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancerWorld J Surg21728732PubMedCrossRef
37.
Zurück zum Zitat Ueno, H, Mochizuki, H, Hashiguchi, Y, Hase, K 2001Prognostic determinants of patients with lateral nodal involvement by rectal cancerAnn Surg234190197PubMedCrossRef Ueno, H, Mochizuki, H, Hashiguchi, Y, Hase, K 2001Prognostic determinants of patients with lateral nodal involvement by rectal cancerAnn Surg234190197PubMedCrossRef
38.
Zurück zum Zitat Shirouzu, K, Ogata, Y, Araki, Y, et al. 2001Total mesorectal excision, lateral lymphadenectomy and autonomic nerve preservation for lower rectal cancer: significance in the long-term follow-up studyKurume Med J48307319PubMed Shirouzu, K, Ogata, Y, Araki, Y,  et al. 2001Total mesorectal excision, lateral lymphadenectomy and autonomic nerve preservation for lower rectal cancer: significance in the long-term follow-up studyKurume Med J48307319PubMed
39.
Zurück zum Zitat Shimoyama, M, Yamazaki, T, Suda, T, Hatakeyama, K 2003Prognostic significance of lateral lymph node micrometastases in lower rectal cancer: an immunohistochemical study with CAM5.2Dis Colon Rectum46333339PubMedCrossRef Shimoyama, M, Yamazaki, T, Suda, T, Hatakeyama, K 2003Prognostic significance of lateral lymph node micrometastases in lower rectal cancer: an immunohistochemical study with CAM5.2Dis Colon Rectum46333339PubMedCrossRef
40.
Zurück zum Zitat Ueno, M, Oya, M, Azekura, K, et al. 2005Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancerBr J Surg92756763PubMedCrossRef Ueno, M, Oya, M, Azekura, K,  et al. 2005Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancerBr J Surg92756763PubMedCrossRef
41.
Zurück zum Zitat Brown, G, Richards, CJ, Bourne, MW, et al. 2003Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparisonRadiology227371377PubMed Brown, G, Richards, CJ, Bourne, MW,  et al. 2003Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparisonRadiology227371377PubMed
42.
Zurück zum Zitat Matsuoka, H, Nakamura, A, Masaki, T, et al. 2003Comparison between endorectal coil and pelvic phased-array coil magnetic resonance imaging in patients with anorectal tumorAm J Surg185328332PubMedCrossRef Matsuoka, H, Nakamura, A, Masaki, T,  et al. 2003Comparison between endorectal coil and pelvic phased-array coil magnetic resonance imaging in patients with anorectal tumorAm J Surg185328332PubMedCrossRef
Metadaten
Titel
Indication and Benefit of Pelvic Sidewall Dissection for Rectal Cancer
verfasst von
Kenichi Sugihara, M.D.
Hirotoshi Kobayashi, M.D.
Tomoyuki Kato, M.D.
Takeo Mori, M.D.
Hidetaka Mochizuki, M.D.
Shingo Kameoka, M.D.
Kazuo Shirouzu, M.D.
Tetsuichiro Muto, M.D.
Publikationsdatum
01.11.2006
Erschienen in
Diseases of the Colon & Rectum / Ausgabe 11/2006
Print ISSN: 0012-3706
Elektronische ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-006-0714-z

Weitere Artikel der Ausgabe 11/2006

Diseases of the Colon & Rectum 11/2006 Zur Ausgabe

Colorectal Website Review

Colonoscopy

Letters to the Editor

Botulinum Toxin and Hemorrhoids

Selected Abstracts

Selected Abstracts

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.